CLSD - Chief Financial Officer at Clearside Biomedical Exercises Options Worth $29K | Benzinga
Charles Deignan, Chief Financial Officer at Clearside Biomedical (NASDAQ:CLSD), reported a large exercise of company stock options on September 13, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Deignan, Chief Financial Officer at Clearside Biomedical, a company in the Health Care sector, just exercised stock options worth 34,090 shares of CLSD stock with an exercise price of $0.4.
Clearside Biomedical shares are trading up 1.76% at $0.86 at the time of this writing on Thursday morning. Since the current price is $0.86, this makes Deignan's 34,090 shares worth $29,487.